Val d'Aurelle Cancer Institute Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2010
NCT01237483
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Alternative names

Val d'Aurelle 34298 Montpellier cedex

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Colorectal Neoplasms (Phase 2)

Head and Neck Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 5